Challenges in initiating a lung cancer screening program : Experiences from two VA medical centers
Published by Elsevier Inc..
Establishing a lung cancer screening (LCS) program is an important endeavor that delivers life-saving healthcare to an at-risk population. However, developing a comprehensive LCS program requires critical elements including obtaining institutional level buy-in, hiring necessary personnel, developing appropriate infrastructure and actively engaging primary care providers, subspecialty services, and radiology. The process required to connect such services to deliver an organized LCS program that reaches all eligible candidates must be individualized to each institution's needs and infrastructure. Here we provide detailed experiences from two successful LCS programs, one using a primary care provider-based service and the other using a consult-based service. In each case, we provide the pros and cons of each system. We propose that the decision to setup an ideal LCS program could include a hybrid design that combines aspects of each system.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2022 |
|---|---|
| Enthalten in: |
Seminars in oncology - (2022) vom: 03. Juli |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bujarski, Stephen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Implementation |
|---|
| Anmerkungen: |
Date Revised 16.02.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1053/j.seminoncol.2022.06.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343738708 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343738708 | ||
| 003 | DE-627 | ||
| 005 | 20240217231950.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1053/j.seminoncol.2022.06.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1297.xml |
| 035 | |a (DE-627)NLM343738708 | ||
| 035 | |a (NLM)35853765 | ||
| 035 | |a (PII)S0093-7754(22)00046-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bujarski, Stephen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Challenges in initiating a lung cancer screening program |b Experiences from two VA medical centers |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Published by Elsevier Inc. | ||
| 520 | |a Establishing a lung cancer screening (LCS) program is an important endeavor that delivers life-saving healthcare to an at-risk population. However, developing a comprehensive LCS program requires critical elements including obtaining institutional level buy-in, hiring necessary personnel, developing appropriate infrastructure and actively engaging primary care providers, subspecialty services, and radiology. The process required to connect such services to deliver an organized LCS program that reaches all eligible candidates must be individualized to each institution's needs and infrastructure. Here we provide detailed experiences from two successful LCS programs, one using a primary care provider-based service and the other using a consult-based service. In each case, we provide the pros and cons of each system. We propose that the decision to setup an ideal LCS program could include a hybrid design that combines aspects of each system | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Implementation | |
| 650 | 4 | |a Low Dose CT | |
| 650 | 4 | |a Lung Cancer Screening | |
| 650 | 4 | |a Veterans Health Administration | |
| 700 | 1 | |a Flowers, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Alkhunaizi, Mansour |e verfasserin |4 aut | |
| 700 | 1 | |a Cuvi, Dave |e verfasserin |4 aut | |
| 700 | 1 | |a Sathya, Sneha |e verfasserin |4 aut | |
| 700 | 1 | |a Melcher, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Kheradmand, Farrah |e verfasserin |4 aut | |
| 700 | 1 | |a Holt, Gregory |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Seminars in oncology |d 1974 |g (2022) vom: 03. Juli |w (DE-627)NLM000122998 |x 0093-7754 |7 nnns |
| 773 | 1 | 8 | |g year:2022 |g day:03 |g month:07 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1053/j.seminoncol.2022.06.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 03 |c 07 | ||